GlassScriptPhysician profile
Vladim Bobrovnikov
NPI 1710399563
$1,502.31
in general payments reported to CMS, 2019-2025
21 companies · $99.97 in 2025
The $99.97 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $12.11 · 2021: $799 · 2022: $175 · 2023: $212 · 2024: $204 · 2025: $99.97.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $516.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $516.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Applied Medical Resources Corporation | $658.05 | 2021 | |
| Novo Nordisk INC | $124.13 | 2021 | |
| Hologic Sales and Service, LLC | $87.13 | 2022-2024 | Fluent Fluid Management System, Myosure Tissue Removal Device, Acessa Provu System |
| Myriad Women'S Health, INC. | $85.11 | 2023 | Myrisk |
| Coopersurgical, INC. | $76.48 | 2023-2025 | Endosee, Paragard T 380a, Paragard T 380a |
| Biogen, INC. | $65.40 | 2024-2025 | Zurzuvae |
| Abbvie INC. | $65.35 | 2022-2023 | Liletta |
| Organon LLC | $62.48 | 2022-2024 | |
| Exeltis, USA INC. | $36.61 | 2023-2025 | Slynd |
| Davol INC. | $34.15 | 2023-2024 | |
| Actelion Pharmaceuticals US, INC. | $28.86 | 2022 | |
| Heron Therapeutics, INC. | $27.04 | 2022 | |
| Shield Therapeutics INC | $21.25 | 2024 | |
| Astellas Pharma US INC | $19.14 | 2024 | Veozah |
| Medtronic, INC. | $18.43 | 2024 | Truclear |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $17.35 | 2025 | Harmonic |
| Boston Scientific Corporation | $17.13 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $16.49 | 2024 | |
| Mayne Pharma Commercial LLC | $15.47 | 2023 | |
| Aspira Women'S Health INC | $14.15 | 2024 | Ova1 |
| Lilly USA, LLC | $12.11 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vladim Bobrovnikov listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.